XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Interim Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Research and development, net $ (1,169) $ (1,617)
General and administrative (1,215) (1,302)
Operating loss (2,384) (2,919)
Financing income, net 13 66
Net loss $ (2,371) $ (2,853)
Basic net loss per share $ (0.17) $ (0.36)
Diluted net loss per share $ (0.17) $ (0.36)
Basic weighted average common shares outstanding 14,055,973 8,013,295
Diluted weighted average common shares outstanding 14,055,973 8,013,295